Hu-lu-su-pian ameliorates hepatic steatosis by regulating CIDEA expression in AKT-driven MASLD mice

Hu-lu-su-pian ameliorates hepatic steatosis by regulating CIDEA expression in AKT-driven MASLD mice

IntroductionHu-lu-su-pian (HLSP) is an oral tablet derived from the active compounds of Cucumis melo L., a traditional Chinese medicine. This contemporary formulation is frequently employed in clinical settings for the management of liver ailments. However, the molecular mechanism by which HLSP affe...

Full description

Saved in:
Bibliographic Details
Main Authors: Rumeng Ren, Qi Wang, Dongjie Deng, Aoao Guo, Xin Chen, Yan Meng, Ying Fang, Guohua Zheng, Zhong Xu, Man Li, Junjie Hu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Pharmacology
Subjects:
Hu-lu-su-pian
metabolic dysfunction-associated steatotic liver disease
CIDEA
de novo fatty acid synthesis
lipid droplets
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1503247/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1503247/full

Similar Items